Skip to main content
Premium Trial:

Request an Annual Quote

OncoDNA Closes $20.6M Funding Round

NEW YORK — Belgian molecular diagnostics firm OncoDNA said on Friday that it has closed a €19 million ($20.6 million) Series B financing round.

The round was led by Vesalius Biocapital III and Swisscanto Invest by Zürcher Kantonalbank. Other participants included SFPI-FPIM, CPH Bank, Inventures, Sambrinvest, Sofinim, SRIW, and undisclosed existing investors.

OncoDNA, which raised €7.7 million in 2016, said it will use the new funding to support its international growth, accelerate software development, and to expand its workforce.

"We [have] built a worldwide network of more than several thousand oncologists, OncoDNA Founder and CEO Jean-Pol Detiffe said in a statement. "Our next move is to connect molecular laboratories to our advanced data interpretation tools, which we pride ourselves on now being possible thanks to the support of our new investors."

About a year ago, OncoDNA released its OncoNTRK RNA sequencing assay for solid or liquid biopsies analysis of tumors with potential NTRK gene fusions. A few months before that, it updated its next-generation sequencing-based OncoDeep solid tumor analysis tool.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.